🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data

Business Archived February 14, 2026
Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data
Source: https://finance.yahoo.com/rss/topstories - Read Original
"House Plans for Structures New and Old"
"5000+ Emails weekly."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Commision Art Work or Just pure Beauty."